Expert Review of Vaccines

New approach for cancer vaccines
pp. 309-311(3)

Trial Watch
pp. 313-314(2)

Assaying Potency of Novel Vaccines
pp. 315-318(4)
Author: Sheets, Rebecca

Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines
pp. 319-336(18)
Authors: Mueller, Judith E; Borrow, Raymond; Gessner, Bradford D

Postgenomic approaches to cholera vaccine development
pp. 337-346(10)
Authors: LaRocque, Regina C; Harris, Jason B; Ryan, Edward T; Qadri, Firdausi; Calderwood, Stephen B

Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
pp. 347-363(17)
Authors: Haynes, Barton F; Montefiori, David C

CpG oligonucleotides accelerate and boost the immune response elicited by AVA, the licensed anthrax vaccine
pp. 365-369(5)
Author: Klinman, Dennis M

Respiratory syncytial virus and innate immunity: a complex interplay of exploitation and subversion
pp. 371-380(10)
Author: Johnson, Teresa R

Therapeutic lymphoma vaccines: importance of T-cell immunity
pp. 381-394(14)
Authors: Neelapu, Sattva S; Lee, Seung-Tae; Qin, Hong; Cha, Soung-Chul; Woo, Alison F; Kwak, Larry W

Achieving directed immunostimulating complexes incorporation
pp. 395-403(9)
Authors: Wikman, Maria; Friedman, Mikaela; Pinitkiatisakul, Sunan; Andersson, Christin; Lövgren-Bengtsson, Karin; Lundén, Anna; Ståhl, Stefan